Sanjivani Parenteral Limited Reports Q1 FY27 Results; EBITDA stood at ₹ 43.21 Mn with PAT at ₹ 24.91 Mn

Mumbai: Sanjivani Paranteral Limited (Sanjivani, The Company) (BSE: 531569), one of the emerging players in the pharmaceutical and healthcare manufacturing sector, continued to strengthen its operational performance during the year through improved efficiencies, focused execution, and a customer-centric approach across its business segments, and has announced its Unaudited Financial Results for Q1 FY27.K Key Consolidated...